Cite
HARVARD Citation
Bridgeman, V. et al. (2017). Vessel co‐option is common in human lung metastases and mediates resistance to anti‐angiogenic therapy in preclinical lung metastasis models. Journal of pathology. 241 (3), pp. 362-374. [Online].